基本信息 产品详情 公司简介 推荐产品
网站主页 KBTBD11抗体 KBTBD11抗体
  • KBTBD11抗体—艾普蒂
  • KBTBD11抗体—艾普蒂
  • KBTBD11抗体—艾普蒂

1/3

KBTBD11抗体—艾普蒂

Rabbit Polyclonal KBTBD11 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-18

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:ruihening88@163.com

产品详情:

中文名称:
KBTBD11抗体
英文名称:
Rabbit Polyclonal KBTBD11 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3264 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
KBTBD11

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesKLHDC7C
WB Predicted band size66 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human KBTBD11
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Human metastatic papillary carcinoma(thyroid cancer) tissue lysate, Primary antibody: P06794(KBTBD11 Antibody) at dilution 1/2300, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 2 minutes    


           

参考文献

以下是基于KBTBD11相关研究方向的模拟参考文献示例(请注意,以下内容为假设性示例,实际文献需通过学术数据库核实):

---

1. **文献名称**:*KBTBD11 regulates Treg cell function through ubiquitination of FOXP3*

**作者**:Schmidt, A. et al.

**摘要**:本研究揭示了KBTBD11作为Cullin3连接酶适配蛋白,通过介导FOXP3的泛素化降解调控调节性T细胞(Treg)的功能。实验中使用特异性KBTBD11抗体进行免疫共沉淀(Co-IP)和Western blot验证其相互作用。

2. **文献名称**:*KBTBD11 acts as a tumor suppressor in neuroblastoma by promoting MYCN degradation*

**作者**:Thompson, R. et al.

**摘要**:研究发现KBTBD11在神经母细胞瘤中低表达,通过靶向泛素化降解致癌蛋白MYCN抑制肿瘤进展。免疫组化(IHC)和免疫荧光(IF)实验采用KBTBD11抗体证实其在患者组织中的表达缺失。

3. **文献名称**:*Germline KBTBD11 mutations cause a novel neurodevelopmental disorder*

**作者**:Martinez, L. et al.

**摘要**:首次报道KBTBD11基因突变导致儿童神经发育障碍。研究通过CRISPR敲除模型和患者来源的细胞系,结合KBTBD11抗体进行蛋白质稳定性分析,证明突变导致功能丧失。

4. **文献名称**:*Comparative analysis of commercial KBTBD11 antibodies for specificity and application suitability*

**作者**:Johnson, P. et al.

**摘要**:系统评估了多种市售KBTBD11抗体的特异性,通过敲除/过表达细胞模型验证其适用于Western blot、流式细胞术及免疫沉淀,为后续研究提供抗体选择指南。

---

**建议**:如需真实文献,请通过PubMed、Google Scholar等平台搜索“KBTBD11 antibody”或结合疾病关键词(如“neuroblastoma”“autoimmunity”),并筛选应用抗体技术的原始研究。

       

背景信息

The KBTBD11 (Kelch Repeat and BTB Domain Containing 11) protein is a member of the Kelch superfamily, characterized by its N-terminal BTB (Bric-a-brac, Tramtrack, Broad Complex) domain and C-terminal Kelch repeat motifs. These structural features enable KBTBD11 to participate in protein-protein interactions, potentially serving as a substrate adaptor for Cullin 3 (CUL3)-based E3 ubiquitin ligase complexes. This suggests a role in ubiquitination-mediated protein degradation, a critical regulatory mechanism in cellular processes like cell cycle control and stress response.

KBTBD11 is encoded by a gene located on chromosome 8 (8q24.3) and is expressed in various tissues, with emerging links to neurodevelopment and cancer. Studies associate KBTBD11 dysregulation with intellectual disability and developmental delay syndromes, possibly through disrupted ubiquitination pathways affecting neuronal signaling. In oncology, reduced KBTBD11 expression has been observed in colorectal and lung cancers, implicating it as a potential tumor suppressor. Its interaction with pathways like Notch and Wnt underscores its multifaceted regulatory influence.

KBTBD11 antibodies are essential tools for detecting and quantifying the protein in research applications, including Western blotting, immunohistochemistry, and immunofluorescence. These antibodies aid in elucidating KBTBD11’s tissue distribution, subcellular localization, and expression changes in disease models. While therapeutic applications remain exploratory, understanding KBTBD11’s molecular interactions through antibody-based studies could reveal novel targets for neurological disorders or cancer treatment strategies. Current research focuses on validating antibody specificity and optimizing detection protocols to minimize cross-reactivity with related Kelch family proteins.

       
KBTBD11抗体;KBTBD11;KBTBD11 Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业,

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,蛋白组学,细胞生物学

KBTBD11抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价